Andrew S. Plump

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Samuel Ntonme, by power of attorney, for Andrew S Plump
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Andrew S. Plump

Form 4 holding President, R&D, Director

TAKEDA PHARMACEUTICAL CO LTD

Security class
American Depositary Shares
Shares / value
766,569
Estimated value
$13,108,329
Report date
10 Aug 2026
Price
$17.10
Ownership
Direct
Form 4 holding President, R&D, Director

TAKEDA PHARMACEUTICAL CO LTD

Security class
American Depositary Shares
Shares / value
281,307
Estimated value
Report date
10 Aug 2026
Price
Ownership
By Trust

Insider Reports Filed by Andrew S. Plump

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .